A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT02723071 · COMPLETED

Trial details

NCT number: NCT02723071
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2005-05-01
Primary completion: 2008-01-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.